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Glycopeptide Biosynthesis in Amycolatopsis
mediterranei DSM5908: Function of a Halogenase
and a Haloperoxidase/Perhydrolase
In our attempts to study the biosynthesis of glycopep-
tide antibiotics and to assign the function of the respec-
tive genes [3–5], we have chosen the balhimycin biosyn-
thesis in the actinomycete Amycolatopsis mediterranei
DSM5908 [6] as a model system, since we are able to
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Eberhard-Karls-Universita¨t Tu¨bingen genetically manipulate the producer strain by applying
various cloning techniques [7, 8]. The in vitro as well asD-72076 Tu¨bingen
2 Institut fu¨r Organische Chemie the in vivo activities of balhimycin are similar to those
of vancomycin, but with a slightly increased antibioticEberhard-Karls-Universita¨t Tu¨bingen
D-72076 Tu¨bingen activity toward anaerobic bacteria (for example, Clos-
tridiae) [9]. The chemical structure of vancomycin-type3 Institut fu¨r Biochemie
TU Dresden antibiotics such as balhimycin is based on a central
heptapeptide core, in which at least five residues areD-01062 Dresden
Germany aromatic amino acids linked to each other to form two
diaryl ether rings and one biaryl ring. The aromatic rings
carry various substituents such as sugars and chlorine
atoms. The aglycon of balhimycin as well as the chlorina-Summary
tion pattern are identical with those of vancomycin and
chloroeremomycin (A82846B), which are produced byGlycopeptides are important clinical emergency anti-
different Amycolatopsis strains [10]. However, these gly-biotics consisting of a glycosylated and chlorinated
copeptides differ in their glycosylation pattern (Figureheptapeptide backbone. The understanding of the bio-
1), which has a strong influence on antibiotic activitysynthesis is crucial for development of new glycopep-
[11]. The significance of glycosylation for an increasedtides. With balhimycin as a model system, this work fo-
antibiotic activity has been explained by the tendencycuses on the investigation of the putative halogenase
of some glycopeptides to form dimers [12, 13]. Besidesgene (bhaA) and the putative haloperoxidase/perhy-
glycosylation, the chlorination of the aglycon is of strik-drolase gene (bhp) of the balhimycin biosynthesis gene
ing importance for antibiotic activity. Binding studies ofcluster. An in-frame deletion mutant in the haloperoxi-
monochlorinated and dechlorinated glycopeptide anti-dase/perhydrolase gene bhp (OP696) did not produce
biotics have shown a less-effective binding of D-Ala-D-balhimycin. Feeding experiments revealed that bhp is
Ala peptides and analogs [14, 15]. There may be aninvolved in the biosynthesis of -hydroxytyrosine, a pre-
influence on the position of the binding pocket, as wellcursor of balhimycin. A bhaA in-frame deletion mutant
as on the dimerization of the sugar substituents [15].(PH4) accumulated glycosylated but nonchlorinated bal-
Antibiotic activity tests comparing differently chlori-himycin variants. The mutants indicated that only the
nated glycopeptide antibiotics are in accordance withhalogenase BhaA is required for chlorination of balhi-
these data [11].mycin. Nonglycosylated and/or nonhalogenated me-
In order to reveal the function of the genes of thetabolites can serve as starting points for combinatorial
balhimycin biosynthesis gene cluster and to subse-approaches for novel glycopeptides.
quently vary and manipulate them to obtain new glyco-
peptide antibiotics, we focused our interests on theIntroduction
characterization of the halogenation process. In nature,
halogenated compounds can be found very frequently.Over the years, the glycopeptide antibiotic vancomycin
More than 3000 different metabolites containing carbon-has emerged as an antibiotic of last resort against multi-
halogen bonds have been isolated to date [16]. Theresistant Gram-positive bacteria, as well as methicillin-
proteins first described as halogenating enzymes wereresistant Staphylococcae (MRSA) [1]. However, the oc-
the so-called haloperoxidases [17]. This was followedcurrence of vancomycin-resistant bacteria has been re-
by the discovery of the cofactor- and metal-free haloper-ported recently [2], and it is expected that the number of
oxidases (perhydrolases) [18], which were later shownthese resistances will further increase. This necessitates
to belong to the /-hydrolase family. Structural andthe search for new glycopeptide antibiotics to overcome
mechanistic investigations revealed that they were notthreatening resistances. One precondition is under-
haloperoxidases, but acted as perhydrolases [19]. Ha-standing the biosynthesis of these glycopeptides in or-
loperoxidases and perhydrolases, which require hydro-der to generate new glycopeptide antibiotics via rational
gen peroxide to catalyze halogenation reactions, lackcombinatorial biosynthesis.
substrate specificity and regioselectivity [18]. Further
investigations demonstrated that these enzymes are not
4 Correspondence: wowo@biotech.uni-tuebingen.de involved in the halogenation of antibiotics such as 7-chlo-
5 Present address: Recombinant Antibody Research Group (D0500), rotetracycline [20], chloramphenicol [21], and pyrrolnitrin
German Cancer Research Center, Im Neuenheimer Feld 280,
[22]. Hammer et al. [23] detected the genes of novelD-69120 Heidelberg, Germany.
halogenating enzymes (PrnA and PrnC) by cloning the6 Present address: Combinature Biopharm AG, Robert-Roessle-Str.
10, D-13125 Berlin, Germany. biosynthetic gene cluster of pyrrolnitrin. Biochemical
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Figure 1. Structure of Different Glycopeptide
Antibiotics
Structures of the glycopeptide antibiotics
balhimycin (A. mediterranei DSM5908) and its
variants PH1377 and PH1237, vancomycin (A.
orientalis C329.4), and chloroeremomycin (A.
orientalis A82846).
characterizations of PrnA and PrnC showed that FADH2 and that only the halogenase BhaA is required for the
chlorination during balhimycin biosynthesis.was required for chlorinating activity [24]. Due to their
substrate specificity and regioselectivity, this new class
of FADH2-dependent halogenases, rather than haloper- Results and Discussion
oxidases or perhydrolases, was considered to be in-
volved in halometabolite biosynthesis [18]. Features of the Proteins Encoded
As reported previously, the balhimycin biosynthetic by bhaA and bhp
gene cluster contains a gene (bhaA) putatively coding In the balhimycin biosynthetic gene cluster, the bhaA
for an FADH2-dependent halogenase ([3] and [S.P., P.H., gene was identified downstream of the oxygenase
R.D.S., J.R., D. Heckmann, and W.W. German patent genes oxyA–oxyC [3]. The similarity of the gene product
Wo 00/77182A1, December, 2000]). Here, we report that to the halogenase PrnC from Pseudomonas fluorescens
the balhimycin biosynthetic gene cluster also contains (27% identity, 42% similarity over 355 amino acids, [3]),
which catalyzes the chlorination of an aromatic precur-a gene (bhp) that putatively codes for a perhydrolase
Glycopeptide Halogenation
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Figure 2. Mutational Analysis of the bhp
Gene
(A) Construction of the in-frame deletion mu-
tant OP696. MluI restriction sites are indi-
cated (M). The positions of the probes used
in the Southern blot analysis of OP696 are
drawn above the cluster. bmt, pgat, bpsD,
and oxyD are neighboring genes of bhp. pgat’
and bpsD’ are incomplete copies of the genes
pgat and bpsD, respectively.
(B) Southern blot analysis of OP696 with a
mix of probe 1 and probe 2. The genomic
DNA of A. mediterranei wild-type strain (lane
1) and of OP696 (lane 3) was digested with
MluI. The loss of one MluI cleavage site after
the in-frame deletion of bhp within the chro-
mosome of OP696 leads to the signal at 2.3
kb. Lane 2: DIG-labeled DNA Molecular
Weight Marker VII (Roche).
sor of pyrrolnitrin biosynthesis [25], suggests its function faciens [26] (37% and 33% similarity, respectively). By
sequence comparison, the conserved serine, aspartate,to be that of an FADH2-dependent halogenase. Further-
more, sequence analysis revealed an open reading and histidine residues of perhydrolases were detected
in the amino acid sequence of Bhp at positions 95, 218,frame (bhp), 8.5 kb downstream of bhaA, encoding a
protein of 284 amino acids. and 246, respectively. These residues form the catalytic
triad [19] of these enzymes. The fact that it had beenBhp showed similarities to perhydrolases; for exam-
ple, to BPO-A1 and BPO-A2 from Streptomyces aureo- demonstrated that these perhydrolases are not involved
in the halogenation step during biosynthesis of a number
of halometabolites casts some doubt on the function of
Bhp as a halogenating enzyme in balhimycin biosynthe-
sis. To elucidate which of the two genes, bhaA or bhp,
actually coded for the enzyme responsible for the incor-
poration of the chlorine atoms during balhimycin biosyn-
thesis, mutational analyses were performed.
Inactivation of the Putative PerhydrolaseFigure 3. Bioassay of the Amycolatopsis mediterranei OP696
Gene bhpSupernatant
To investigate whether the bhp gene participates in theBioassay of the OP696 supernatant using B. subtilis after incubation
without () and with () supplementation of -hydroxytyrosine. chlorination of balhimycin or one of its biosynthesis in-
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Figure 4. Analysis of the bha Gene by Inser-
tional Mutagenesis
(A) Construction of the gene disruption mu-
tant PH1. The position of the BamHI restric-
tion sites are indicated (B). The location of
the probe used in the Southern blot is shown.
oxyB, oxyC, bgtfA, and bgtfB are neighboring
genes of bhaA. bhaA’, ‘bhaA, and ‘bhaA’ are
incomplete copies of the gene bhaA.
(B) Southern hybridization of BamHI-linear-
ized genomic DNA of the wild-type (lane 2)
and of PH1 (lane 3), using the 3.1-kb BamHI
fragment as a probe. The 6.7-kb and 1.9-kb
signals in lane 3 indicate the integration of
pPH1 into the wild-type chromosome. The
additional signal at 5.0 kb most likely repre-
sents the linearized vector pPH1, indicating
multiple or tandem integrations. Lane 1: DIG-
labeled DNA Molecular Weight Marker VII
(Roche).
termediates, an in-frame deletion mutant was con- tain a deletion mutant, a mutant in which a second ho-
mologous recombination event has occurred was se-structed. The nonreplicative plasmid pOP1 (for con-
struction, see the Experimental Procedures), carrying lected for (Figure 2A). Since such events happen at a
rather low frequency in A. mediterranei, a “stress” proto-the in-frame deleted bhp gene, was used for transforma-
tion of the wild-type strain Amycolatopsis mediterranei col (see the Experimental Procedures) has been devel-
oped whose application increases the probability of aby means of a modified direct transformation [8]. Via a
first homologous recombination process, several eryth- second cross-over event. Following application of this
“stress” protocol, 900 colonies were examined on R5romycin-resistant clones were generated, which con-
tained the pOP1 plasmid integrated into the genome. plates with and without erythromycin. Five of the tested
colonies had lost the plasmid, as indicated by the lackOne of the integration mutants was selected, and the
correct integration of pOP1 by homologous recombina- of erythromycin resistance. A Bacillus subtilis bioassay
showed that all of these five colonies were unable totion into the chromosomal bhp gene was analyzed by
Southern hybridization (data not shown). In order to ob- produce balhimycin, indicating that, in all cases, the
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Figure 5. Analysis of the bha Gene by Gene
Replacement and Deletion
(A) Construction of the gene replacement mu-
tant PH3. ‘oxyC and bgtfA’ are incomplete
copies of the genes oxyC and bgtfA, respec-
tively.
(B) Construction of the in-frame deletion mu-
tant PH4. The relevant restriction sites are
shown: B, BamHI; Bg, BglII.
second cross-over had led to the exchange of the wild- family and that they are not present in the biosynthetic
type allele against the deleted bhp gene (Figure 2A). The gene clusters of halometabolites like 7-chlorotetracy-
loss of balhimycin production in these strains clearly cline [20], pyrrolnitrin [22], and pyoluteorin [28].
demonstrates the participation of Bhp in the biosynthe-
sis of balhimycin. One of these balhimycin null mutants,
OP696, was analyzed in detail by Southern hybridization, Studies of the Function of Bhp in Providing
which confirmed the internal deletion of bhp (Figure 2B). Nonproteinogenic Amino Acids by Feeding
OP696 with -Hydroxytyrosine
Downstream of bhp, the gene bpsD has been identifiedChemical Analysis of Intermediates Isolated
encoding a nonribosomal peptide synthetase domain.from OP696 Culture Filtrates
Feeding studies using a bpsD gene disruption mutantCulture filtrates of OP696 were investigated by HPLC-
have shown that BpsD participates in the formation ofESI-MS analysis. However, in accordance with the lack
-hydroxytyrosine (J.R. et al., unpublished data), mostof antibiotic activity, neither balhimycin nor intermedi-
likely by activating a tyrosine residue for the hydroxyla-ates with molecular masses above 200 Da were detected
tion reaction. This assumption agrees with the results ofin culture filtrates of OP696. The lack of balhimycin or
studies on the role of the homologous protein NovH inits precursors in the culture filtrates of OP696 suggests a
novobiocin biosynthesis [29]. Since bhp and bpsD arerole of Bhp in an early step of the biosynthesis. However,
cotranscribed (O.P., unpublished data), we assumed thatsince dechlorinated glycopeptide compounds have
Bhp may participate in the synthesis of -hydroxytyro-been isolated together with balhimycin [27], inactivity
sine. To prove this, OP696 was cultivated in the presenceor lack of the chlorinating enzyme should not result in
of this amino acid. A bioassay with B. subtilis demon-blocked balhimycin formation. Thus, the fact that bhp
strated that OP696 is able to produce active balhimycinmutants are balhimycin nonproducers suggests a role
after feeding -hydroxytyrosine (Figure 3).of Bhp in a biosynthesis step different from halogena-
Since a putative thioesterase domain [30] is detect-tion. This conclusion is in accordance with the finding
that these types of enzymes belong to the /-hydrolase able in the amino acid sequence of Bhp (position 87–109,
Chemistry & Biology
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Figure 6. Chemical Characterization of Products from PH4 and Wild-Type
(A) Mass spectra of balhimycin variants produced by PH4 and the wild-type strain (WT) with a mass shift of m  68 amu. The balhimycin
variants indicated by the mass peaks are described in Table 1.
(B) Analysis of the isotopic pattern of balhimycin variants produced by PH4 and the wild-type strain (left). Right side: theoretically calculated
isotopic patterns for nonchlorinated balhimycin (above) and for fully chlorinated balhimycin (below).
SPCRVVGTSMGSYIAQELALARP), one may speculate plasmid pPH1 had integrated into the chromosome of
the wild-type strain via homologous recombination (Fig-that Bhp catalyzes the release of the -hydroxylated
tyrosine from BpsD by thioester bond hydrolyzation. ure 4B). The formation of an inhibition zone in the bio-
assay with B. subtilis demonstrated that, in contrast toThis putative enzymatic release is in contrast with the
proposed reactions in novobiocin biosynthesis. In the the null mutant OP696, PH1 still produced antibiotically
active compounds (data not shown).novobiocin gene cluster [31], no gene with similarities
to bhp was detected. For novobiocin biosynthesis, it
has been postulated that the -hydroxylated tyrosine Chemical Characterization of the Biosynthesis
undergoes further modifications before the product Products of the Disruption Mutant PH1
(amino-coumarin) is released from NovH by the nucleo- To identify the balhimycin variants produced by PH1,
philic attack of an ortho-hydroxy group [29]. the culture filtrate of this strain was analyzed by HPLC-
ESI-MS. The mass spectrum indicated the production
Inactivation of the Halogenase Gene bhaA of the substance PH1237 (Figure 1) and its variants,
by Gene Disruption all lacking the dehydrovancosamine residue, as well as
In order to prove the halogenating function of BhaA, a both chlorine atoms (data not shown). The chlorination
bhaA gene disruption mutant was constructed. The defect caused by the disruption of bhaA indicated that
wild-type strain A. mediterranei DSM5908 was trans- BhaA catalyzes the chlorination of balhimycin at both
formed by the direct transformation method [8] with the positions. The partial or complete lack of glycosylation
plasmid pPH1 (for construction, see the Experimental can be attributed to polar effects on the glycosyl trans-
Procedures), a nonreplicative vector carrying an internal ferase genes downstream of bhaA, particularly on the
bhaA gene fragment. This experiment resulted in the bgtfA gene. BgtfA significantly resembles GtfA [3], which
erythromycin-resistant transformant PH1 (Figure 4A). A is considered to be the enzyme attaching 4-epi-vanco-
Southern hybridization analysis of PH1 revealed that the samine to the backbone of chloroeremomycin [32]. A
polar effect on the bgtfA gene, therefore, would explain
the lack of the dehydrovancosamine residue in the vari-
Table 1. Balhimycin Variants Produced by PH4 and the Wild- ants synthesized by PH1. However, from the results
Type Strain presented above, a function of BhaA in glycosylation
Strain m/z Balhimycin Variant cannot be excluded. Therefore, the construction of an
in-frame deletion was necessary.PH4 1396 PH1377 (see Figure 1), ammonium-ionized
1377 PH1377
1237 PH1237 (see Figure 1) Inactivation of bhaA by an In-Frame Deletion
1075 Non chlorinated aglycon The construction of the in-frame deletion mutants as
Wild-type 1466 Balhimycin, ammonium-ionized described for OP696 is a time-consuming procedure.
1445 Balhimycin The detection of the second cross-over step can require
1305 Chlorinated, glucosylated peptide backbone
testing of a large number of colonies even after applying
Glycopeptide Halogenation
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Table 2. Bacterial Strains and Plasmids Used in This Study
Source or
Strain or Plasmid Properties Reference
E. coli XL1-blue General cloning host [43]
A. mediterranei DSM5908 Balhimycin-producing wild-type [6]
A. mediterranei OP696 Balhimycin non producing mutant, in-frame deletion in the bhp This study
gene
A. mediterranei PH1 Balhimycin non producing mutant, disruption of bhaA by the This study
plasmid pPH1
A. mediterranei PH4 Balhimycin non producing mutant with an in-frame deletion in This study
the bhaA gene
A. mediterranei PH4-2 PH4 complemented with an additional bhaA gene This study
pJOE890 APR [44]
pSP1 Gene disruption vector; EryR [8]
pLitmus28 ApR [45]
pUC18 ApR [46]
pUC18ermEp1 ApR [47]
pSET152 AmR; integration system of the phage φC31 [48]
pIJ877 pBR322 derivative containing the cat gene [33]
pUC18B3.0 pUC18 derivative containing a 3.1-kb BamHI fragment of the This study
balhimycin biosynthetic gene cluster including the bhaA gene
pUC18bhp pUC18 derivative containing a 8.5-kb BglII fragment of the balhi- This study
mycin biosynthetic gene cluster including the bhp gene
pPH1 pSP1 derivative containing an internal part of the bhaA gene This study
pSETbhaA pSET152 derivative containing the bhaA gene under the control This study
of the ermEp1-promoter
pUC18hal3 pUC18 derivative containing the fragment frSP1 (see the Experi- This study
mental Procedures)
pUC18HalermE pUC18ermEp1 derivative containing the fragment frSP1 (see the This study
Experimental Procedures)
pUC18B pUC18 derivative containing a part of the balhimycin biosyn- This study
thetic gene cluster including the bhaA gene with a 969-bp in-
frame deletion
pPH4 pSP1 derivative containing a part of the balhimycin biosynthetic This study
gene cluster including the bhaA gene with a 969-bp in-frame
deletion
pPH3 pSP1 derivative containing a part of the balhimycin biosynthetic This study
gene cluster including the bhaA gene partly exchanged with
the cat cassette
pUC6cat pUC18 derivative containing a part of the balhimycin biosyn- This study
thetic gene cluster including the bhaA gene partly exchanged
with the cat cassette
pOP1 pSP1 derivative containing a part of the balhimycin biosynthetic This study
gene cluster including the bhp gene with a 408-bp in-frame
deletion
pJOEOP1 pJOE890 derivative containing the fragment frOP1 (see the Ex- This study
perimental Procedures)
pJOEOP2 pJOE890 derivative containing the fragment frOP2 (see the Ex- This study
perimental Procedures)
pSPOPa pSP1 derivative containing the fragment frOP2 (see the Experi- This study
mental Procedures)
pLitmus28OPa pLitmus28 derivative containing the fragment frOP1 (see the This study
Experimental Procedures)
Am, apramycin; Ap, ampicillin; Ery, erythromycin.
the “stress” protocol. Since the recombination events to differentiate between single cross-over (erythromycin
resistant) and double cross-over (erythromycin sensi-that lead back to the wild-type genotype cannot be
distinguished by the resistance pattern from those that tive). The mutant PH3 was chloramphenicol resistant
and erythromycin sensitive, indicating a double cross-result in the mutant genotype, a labor-intensive screen-
ing procedure by PCR and/or Southern hybridization is over (Figure 5A). A Southern blot experiment revealed
the correct integration of the cat gene into the chromo-necessary. We, therefore, developed a modified strat-
egy for the construction of the bhaA deletion strain. In somal bhaA gene (data not shown). To replace the cat
cassette by an in-frame deletion, PH3 was transformedthe first step, the plasmid pPH3 (constructed via a new
inverse PCR technique, see the Experimental Proce- with the plasmid pPH4 that contains the mutated bhaA
gene. After applying the stress protocol, 3 out of 250dures) including bhaA disrupted by the chloramphenicol
resistance gene cat [33] was used to transform A. med- tested colonies revealed the necessary resistance pat-
tern (erythromycin sensitive and chloramphenicol sensi-iterranei. Several chloramphenicol-resistant transfor-
mants were analyzed on erythromycin-containing media tive), whereas no colony was detected (0/200) without
Chemistry & Biology
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Figure 7. Construction of Plasmids Used for
Mutational Analyses
(A) Amplification of the fragment frPH1. See
the text for further details. “bhaA and bhaA”
are incomplete copies of the gene bhaA.
(B and C) Construction of the plasmids (B)
pPH4 and (C) pPH3. The relevant restriction
sites are indicated: B, BamHI; Bg, BglII; Bc,
BclI; E, EcoRI; M, MluI; S, SphI. See the text
for further details.
stressing. The sensitive mutant strain PH4 was isolated, pattern was not affected by the in-frame deletion, since
completely glycosylated variants were detectable (Fig-and the exchange of the cat cassette against the dele-
ure 6A; Table 1). Since both chlorine atoms are missing,tion by a double cross-over event (Figure 5B) was proven
bhaA is responsible for the halogenation at amino acidsby Southern hybridization (data not shown). Like the
2 and 6 of balhimycin. The occurrence of fully glycosy-disruption mutant PH1, PH4 is also able to produce
lated balhimycins in PH4 demonstrated that BhaA is notantibiotically active compounds, as demonstrated by
involved in glycosylation. Furthermore, it can now bebioassays (data not shown).
ruled out that halogenation is a precondition for subse-
quent biosynthesis steps. The different glycosylation
Chemical Characterization of Biosynthesis degrees of the compounds synthesized by PH4 can be
Products of the Deletion Mutant PH4 explained by natural variety, since differently glycosy-
For analysis of the glycosylation pattern and the chlori- lated balhimycin variants were also found in wild-type
nation degree of the balhimycin variants synthesized filtrates (Figure 6A; Table 1). This is in agreement with
by PH4, samples of culture filtrates were submitted to observations of Ve´rtesy et al. [27], who isolated up to ten
HPLC-ESI-MS. According to the isotopic pattern, all bal- different analogs of balhimycin from wild-type culture
himycin variants synthesized by PH4 completely lacked filtrates.
chlorine atoms (Figure 6B). Furthermore, characteristic
mass shifts of 68 atomic mass units (amu) to lower Complementation of the bhaA Gene Defect in PH4
masses in comparison with the corresponding signals To prove that only the in-frame deletion of bhaA was
from the wild-type culture broth also indicated the ab- responsible for the loss of both chlorine atoms in the
sence of both chlorine atoms (Figure 6A). In contrast balhimycin variants produced by PH4, we comple-
mented this mutant by integrating a copy of bhaA intoto the gene disruption mutant PH1, the glycosylation
Glycopeptide Halogenation
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“Stress” Protocol for Increasing the Frequency of Cross-the chromosome. For this purpose, the integrative plas-
Over Events in A. mediterraneimid pSETbhaA (for construction, see the Experimental
After growth in 25 ml R5 medium [38] for 48 hr at 30C, the myceliumProcedures) was introduced by the direct transforma-
of the A. mediterranei strain was harvested by centrifugation and
tion method [8]. By selection on apramycin-containing resuspended in 12.5 ml R5. Then, fragmentation of the mycelium
media, the complementation mutant PH4-2 was iso- was induced using an ultrasound bath (Bandelin Sonorex RK100;
lated. The integration of pSETbhaA into the chromo- 15 min), followed by an additional incubation for 2 hr at elevated
temperature conditions (37C) in 100 ml R5. For further fragmenta-some of PH4-2 via the φC31 attachment site (attb) was
tion, an additional ultrasound treatment (Branson Sonifier 250; 5demonstrated by Southern analysis (data not shown).
mm standard-microtip; 10 s, 50% duty cycle, output control stepSince attb lies outside of the balhimycin biosynthetic
5) was performed. After storage on ice (10 min), 100 l of differentcluster (S.P., unpublished data), none of the biosynthetic
dilutions (101–105) of the cells was plated on R5 agar plates. After
genes was affected by the integration of pSETbhaA. incubation at 30C for 3–5 days, a few hundred colonies were ob-
HPLC-ESI-MS investigations of PH4-2 culture filtrates tained and used for further investigations.
showed the existence of chlorinated balhimycin to-
gether with partially and nonchlorinated variants (data Cultivation of OP696 in the Presence of -Hydroxytyrosine
OP696 (Table 2) was incubated under standard conditions in 10 mlnot shown). The failure of a complete restoration of chlo-
R5 medium [38], containing dissolved -hydroxytyrosine that hadrination could result from a positional effect. Alterna-
been synthesized according to Bolhofer [39] at a concentration oftively, differences of the expression level of the bhaA
0.8 mg ml1. The supernatant was harvested after 50 hr, and 20 lgene in the wild-type and in PH4-2 may cause this effect, was used to determine the production of balhimycin in a bioassay
since, in PH4-2, bhaA is under the control of the constitu- with B. subtilis.
tive promoter ermEp1 [34, 35], whereas the native bhaA
gene is expressed from a promoter in the cluster. Com- Preparation, Manipulation, and Sequencing of DNA
Methods for isolation and manipulation of DNA were as describedparable observations were reported, for example, on
by Sambrook et al. [37] and Hopwood et al. [38]. Plasmid isolationcomplementation experiments of a Streptomyces cla-
for sequencing was performed with the High Pure Plasmid Purifica-vuligerus ccaR mutant strain [36].
tion Kit (Roche). PCR fragments were isolated from agarose gelsThe natural substrate of BhaA and, therefore, the bio-
with QIAquick (Qiagen). Restriction endonucleases were obtained
synthetic step on which halogenation takes place is still from various suppliers and were used according to their specifica-
unclear. Other A. mediterranei mutant strains, however, tions. For sequencing reactions, the ALFexpress AutoRead kit
can give some insights into the halogenation time point. (Amersham Pharmacia Biotech AB) or the Thermo Sequenase fluo-
rescent-labeled primer cycle sequencing kit with 7-deaza-dGTPThe linear heptapeptide SP-1134 [3, 4] of the oxygenase
(Amersham Pharmacia Biotech AB) were used, according to themutant SP1-1, as well as HD1, which is glycosylation
suppliers’ instructions. Sequencing data were generated by usingdeficient [3], are both chlorinated. Therefore, an early
the ALFexpress DNA sequencer (Amersham Pharmacia Biotech AB).stage of chlorination prior to oxidative bridging by
Alignment of sequence contigs and examination for open reading
the oxygenases OxyA/B/C, possibly with tyrosine or frames (ORFs) were performed by applying gap4 and nip4 [40].
-hydroxytyrosine as the substrate, seems likely. In or- BLAST [41] and FASTA [42] were used for homology searches.
der to elucidate the natural substrate for the halogenase
BhaA, further work is being performed via overexpres- PCR Protocols for Amplification of the Fragments frOP1,
frOP2, frSP1, frPH1, and frPH2sion and biochemical characterization studies.
PCR was performed on a Robo Cycler Gradient 40 thermocycler
from Stratagene with the Expand High Fidelity PCR System (Roche).Significance
The PCR mixture (100 l) contained 100 pmol of each primer, 1.0
g template DNA (pUC18bhaA or pUC18bhp), deoxyribonucleoside
The results of this study demonstrate for the first time 5	-triphosphates at a final concentration of 200 M each (DNA Poly-
that a single halogenase is responsible for the incorpo- merization Mix; Pharmacia), 10
 reaction buffer, 1.5 mM MgCl2, and
3.5 U Taq DNA polymerase. Dimethyl sulfoxide at a final concentra-ration of the two chlorine atoms of the glycopeptide
tion of 3% was added to the reaction mixture to enhance the speci-antibiotic balhimycin, while a perhydrolase-like en-
ficity of hybridization. For amplification of the fragments, the follow-zyme is required for the biosynthesis of -hydroxy-
ing PCR procedure was used: initial denaturation (94C; 3 min) beforetyrosine. Techniques for the construction of in-frame
the addition of the polymerase; 30 cycles of denaturation (94C; 1
deletion mutants of the balhimycin-producing strain min), annealing (60C; 1 min), and polymerization (72C; 2 min); and
were optimized. With the help of these more-efficient an additional polymerization step (72C; 10 min) at the end. The
techniques, glycopeptide production can be rationally sequences of the primers were as follows: amplification of the frag-
ment frOP1: prOP1-1, 5	-GGGCATGCCGGTCTTGGCGAAGGAGCmanipulated with defined mutant strains. By heterolo-
CG-3	, prOP1-2, 5	-ACAGATCTCGGCGCCCCGGTGCCGGTCAG-3	;gous gene expression and/or with the help of feeding
amplification of the fragment frOP2: prOP2-1, 5	-AAAGATCTGCexperiments, a new generation of modified glycopep-
CGACTGGCTCGACCTGTTC-3	, prOP2-2, 5	-GATCTAGACGCGtides is expected to develop in the future.
G C CG G CG G CC C AG CG C T T-3	; amplification of the fragment
frSP1: BhaA2RBS, 5	-AAGGATCCTCGGCAATTTGACACTCGAC-3	,Experimental Procedures
BhaAC, 5	-TTTCTAGAGGTTGTTCCGCAGGTCCCGGCC-3	; ampli-
fication of the fragment frPH1: Primer2, 5	-CTCACAGATCTGATAStrains and Plasmids
CCGCGGGAAA-3	, Primer3, 5	-CTACCAGATCTACGTGAACGAThe strains and plasmids used in this study are listed in Table 2.
GGAG-3	; amplification of the fragment frPH2: Primer4, 5	-AAGCGC
GGCGGCACGTTCCGCTGGG-3	, Primer5, 5	-CACTGCGCGCGGCGMedia and Culture Conditions
ATGCGGTCGGC-3	.Escherichia coli strains were grown in Luria broth [37], supple-
mented with 150 g ml1 ampicillin or 100 g ml1 apramycin when
Southern Hybridizationnecessary to maintain plasmids. A. mediterranei strains were grown
Digests of genomic Amycolatopsis DNA were separated in 1% aga-in R5 medium [38] at 30C. Liquid/solid media were supplemented
rose gels in Tris-acetate buffer and transferred to Hybond-N Nylonwith 50 g ml1 erythromycin or 50 g ml1 apramycin to select for
strains carrying integrated antibiotic resistance genes. membranes (Amersham Pharmacia Biotech AB). For labeling of DNA
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probes and hybridization, the nonradioactive DIG DNA Labeling and HPLC-ESI-MS
Investigations of the balhimycin variants in the culture broths wereDetection Kit from Roche was used at high stringency (0.1% SDS,
0.1
SSC, 68C). Oligonucleotides were labeled using the DIG Oligo- performed via HPLC-ESI-MS analysis. Culture broths were prepared
by centrifugation and filtration to obtain particle-free samples (sam-nucleotide Tailing Kit (Roche) and detected by the chemiluminescent
reaction. As a size standard, the DIG-labeled DNA Molecular Weight ple injection volume: 100 l), which were introduced via a double
syringe pump (Applied Biosystems, Model 140A) to the HPLC-MS.Marker VII (Roche) with the following fragment lengths (in base pairs)
was used: 81; 359; 492; 710; 718; 992; 1,164; 1,482; 1,515; 1,882; Separations were performed on a Nucleosil C-18 column (2 

100 mm, 5 m) (Grom) with a flow rate of 200 l min1. The UV1,953; 2,799; 3,639; 4,899; 6,106; 7,427; and 8,576.
detector (UVIS 204, Linear) was connected in series with the mass
spectrometer (  214 nm). The following gradient was used: t  0Construction of the Plasmids pOP1, pPH1, pPH3, pPH4,
and pSETbhaA min: 5% B; t  1 min: 17% B; t  15 min: 20% B; t  17 min: 100%
B (solvent A: 0.1% TFA in water, solvent B: 0.1% TFA in acetonitrile).Plasmids were constructed for the internal deletion of the perhy-
drolase gene bhp (pOP1), for disruption of the halogenase gene Mass spectra were recorded on a Perkin Elmer API III TAGA SCIEX
bhaA (pPH1), for the internal deletion of bhaA (pPH3, pPH4), and Triple Quadrupole mass spectrometer (Thornhill), equipped with an
for complementation of the mutant strain A. mediterranei PH4 electrospray ion source (ESI). The LC mobile phase flow rate was
(pSETbhaA). The relevant regions of the plasmid constructs were reduced by means of a splitter down to 70 l min1, before introduc-
verified by sequencing. tion into the ES interface. The orifice voltage was set to 80V in
pOP1 positive ion mode.
The 1,116-bp fragment frOP1 including the sequence encoding 32
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